Hematopoietic cell transplantation for myeloid/ NK  cell precursor acute leukemia in second remission | Zendy

Noguchi Yusuke | Zendy; Tomizawa Daisuke | Zendy; Hiroki Haruka | Zendy; Miyamoto Satoshi | Zendy; Tezuka Mari | Zendy; Miyawaki Reiji | Zendy; TanakaKubota Mari | Zendy; Okano Tubasa | Zendy; Kobayashi Chika | Zendy; Mitsuiki Noriko | Zendy; Aoki Yuki | Zendy; Imai Kohsuke | Zendy; Kajiwara Michiko | Zendy; Kanegane Hirokazu | Zendy; Morio Tomohiro | Zendy; Takagi Masatoshi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hematopoietic cell transplantation for myeloid/ NK cell precursor acute leukemia in second remission

Author(s) -

Noguchi Yusuke,

Tomizawa Daisuke,

Hiroki Haruka,

Miyamoto Satoshi,

Tezuka Mari,

Miyawaki Reiji,

TanakaKubota Mari,

Okano Tubasa,

Kobayashi Chika,

Mitsuiki Noriko,

Aoki Yuki,

Imai Kohsuke,

Kajiwara Michiko,

Kanegane Hirokazu,

Morio Tomohiro,

Takagi Masatoshi

Publication year - 2018

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.1506

Subject(s) - medicine , myeloid leukemia , hematopoietic cell , transplantation , hematopoietic stem cell transplantation , myeloid , precursor cell , immunology , cell , haematopoiesis , leukemia , cancer research , stem cell , biology , microbiology and biotechnology , genetics

Key Clinical Message Myeloid/natural killer cell precursor acute leukemia ( MNKPL ) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia‐type chemotherapy combined with L‐Asparaginase is an effective treatment for MNKPL . Hematopoietic cell transplantation is a second option in refractory cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research